Joana Goncalves
No más puestos en curso
Fortuna: 34 634 $ al 31/05/2024
Perfil
Joana Goncalves worked as the Vice President-Medical Affairs & Neurology at Celgene Corp.
from 2014 to 2018.
Prior to that, she was the VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc. from 2012 to 2014.
Currently, she is serving as the Chief Medical Officer at CARA Therapeutics, Inc. since 2018.
Dr. Goncalves holds a doctorate degree from the University of Cape Town.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0.10% | 05/04/2024 | 53 365 ( 0.10% ) | 34 634 $ | 31/05/2024 |
Antiguos cargos conocidos de Joana Goncalves.
| Empresas | Cargo | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 16/04/2024 |
| CELGENE | Director Técnico/Científico/I+D | 01/10/2018 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Director Técnico/Científico/I+D | 01/04/2014 |
Formación de Joana Goncalves.
| University of Cape Town | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
- Bolsa de valores
- Insiders
- Joana Goncalves
